T细胞疗法-话题@MedSci

#T细胞疗法#

95篇内容 | 3221人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1477996, encodeId=109c14e799696, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？, objectType=article, longId=130441, objectId=33e2130441cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33e2130441cc, replyNumber=0, likeNumber=73, createdTime=2018-02-25, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33e2130441cc, moduleTitle=Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33e2130441cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477995, encodeId=271314e799576, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=PLoS Pathog：CAR-T细胞疗法再现颠覆性进展，助力实现艾滋病功能性痊愈！, objectType=article, longId=125066, objectId=98f0125066ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98f0125066ce, replyNumber=0, likeNumber=75, createdTime=2017-12-31, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98f0125066ce, moduleTitle=PLoS Pathog：CAR-T细胞疗法再现颠覆性进展，助力实现艾滋病功能性痊愈！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98f0125066ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477994, encodeId=e85514e7994c9, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=CAR-T细胞疗法金矿急待开发，全球自动化铁锹诞生, objectType=article, longId=121305, objectId=8705121305a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8705121305a7, replyNumber=0, likeNumber=71, createdTime=2017-11-26, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8705121305a7, moduleTitle=CAR-T细胞疗法金矿急待开发，全球自动化铁锹诞生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8705121305a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477993, encodeId=adf414e7993a0, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=美国FDA授予Lion TCR两项针对肝癌T细胞疗法的孤儿药物资格, objectType=article, longId=110518, objectId=cc0311051889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc0311051889, replyNumber=0, likeNumber=78, createdTime=2017-08-24, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc0311051889, moduleTitle=美国FDA授予Lion TCR两项针对肝癌T细胞疗法的孤儿药物资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc0311051889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477992, encodeId=158214e7992f4, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=开发T细胞疗法&nbsp武田或将$1亿收购Gammadelta&nbspTherapeutics, objectType=article, longId=98383, objectId=f6769838393, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6769838393, replyNumber=0, likeNumber=66, createdTime=2017-05-12, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6769838393, moduleTitle=开发T细胞疗法&nbsp武田或将$1亿收购Gammadelta&nbspTherapeutics, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6769838393)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477991, encodeId=c36814e799131, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=梳理CAR-T细胞疗法研究新近进展, objectType=article, longId=98395, objectId=64c598395cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64c598395cb, replyNumber=0, likeNumber=67, createdTime=2017-05-02, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64c598395cb, moduleTitle=梳理CAR-T细胞疗法研究新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64c598395cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477990, encodeId=e83814e799086, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=Science：重大突破！利用CAAR-T细胞疗法靶向治疗自身免疫疾病, objectType=article, longId=72030, objectId=81fde2030bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81fde2030bc, replyNumber=0, likeNumber=74, createdTime=2016-07-05, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81fde2030bc, moduleTitle=Science：重大突破！利用CAAR-T细胞疗法靶向治疗自身免疫疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81fde2030bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477989, encodeId=315c14e798949, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=CAR-T细胞疗法在实体肿瘤治疗中的五大难点, objectType=article, longId=70999, objectId=d646e099951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d646e099951, replyNumber=0, likeNumber=68, createdTime=2016-06-18, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d646e099951, moduleTitle=CAR-T细胞疗法在实体肿瘤治疗中的五大难点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d646e099951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477988, encodeId=09be14e7988c4, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=Lancet：Ixmyelocel-T细胞疗法或将是HFrEF患者的福音, objectType=article, longId=66121, objectId=528e66121d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=528e66121d4, replyNumber=0, likeNumber=59, createdTime=2016-04-07, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=528e66121d4, moduleTitle=Lancet：Ixmyelocel-T细胞疗法或将是HFrEF患者的福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=528e66121d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477987, encodeId=f06014e798704, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=【盘点】CAR-T细胞疗法进展一览, objectType=article, longId=64052, objectId=9c9364052d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c9364052d6, replyNumber=0, likeNumber=78, createdTime=2016-03-04, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c9364052d6, moduleTitle=【盘点】CAR-T细胞疗法进展一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c9364052d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477986, encodeId=d41e14e7986dd, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=癌症治愈？过继T细胞疗法可靶向治疗疾病, objectType=article, longId=63515, objectId=a85c635154e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a85c635154e, replyNumber=0, likeNumber=85, createdTime=2016-02-21, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a85c635154e, moduleTitle=癌症治愈？过继T细胞疗法可靶向治疗疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a85c635154e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477985, encodeId=f11c14e798593, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=震撼：CAR-T细胞疗法CTL019在2期r/r ALL临床试验中获得93%的完全应答率, objectType=article, longId=60483, objectId=3e7a604835d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e7a604835d, replyNumber=0, likeNumber=62, createdTime=2015-12-11, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e7a604835d, moduleTitle=震撼：CAR-T细胞疗法CTL019在2期r/r ALL临床试验中获得93%的完全应答率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e7a604835d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477984, encodeId=247014e798402, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=ASCO 2015：CAR-T细胞疗法正在攻克实体瘤胰腺癌是初露曙光, objectType=article, longId=52363, objectId=e3d552363ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3d552363ff, replyNumber=0, likeNumber=40, createdTime=2015-06-21, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3d552363ff, moduleTitle=ASCO 2015：CAR-T细胞疗法正在攻克实体瘤胰腺癌是初露曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3d552363ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477983, encodeId=c28c14e798333, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=用于抗癌的嵌合抗原受体T细胞疗法目前已经进入临床试验阶段, objectType=article, longId=45685, objectId=ffa745685e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffa745685e8, replyNumber=0, likeNumber=69, createdTime=2015-01-21, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffa745685e8, moduleTitle=用于抗癌的嵌合抗原受体T细胞疗法目前已经进入临床试验阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffa745685e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477982, encodeId=995c14e7982de, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=Nature：T细胞疗法可延长白血病患者生存期？, objectType=article, longId=44934, objectId=d46844934d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d46844934d3, replyNumber=0, likeNumber=76, createdTime=2015-01-06, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d46844934d3, moduleTitle=Nature：T细胞疗法可延长白血病患者生存期？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d46844934d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477981, encodeId=523914e79816d, content=<a href='/topic/show?id=bb6f18030a4' target=_blank style='color:#2F92EE;'>#T细胞疗法#</a>, objectTitle=美科学家致力T细胞疗法治疗癌症, objectType=article, longId=20736, objectId=bdba20e36d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdba20e36d1, replyNumber=0, likeNumber=52, createdTime=2013-07-03, rootId=0, userName=124984edm24暂无昵称, userId=6bea7392214, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdba20e36d1, moduleTitle=美科学家致力T细胞疗法治疗癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdba20e36d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

T细胞疗法

2020-05-29

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？

2018-02-25

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

PLoS Pathog：CAR-T细胞疗法再现颠覆性进展，助力实现艾滋病功能性痊愈！

2017-12-31

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

CAR-T细胞疗法金矿急待开发，全球自动化铁锹诞生

2017-11-26

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

美国FDA授予Lion TCR两项针对肝癌T细胞疗法的孤儿药物资格

2017-08-24

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

开发T细胞疗法&nbsp武田或将$1亿收购Gammadelta&nbspTherapeutics

2017-05-12

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

梳理CAR-T细胞疗法研究新近进展

2017-05-02

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

Science：重大突破！利用CAAR-T细胞疗法靶向治疗自身免疫疾病

2016-07-05

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

CAR-T细胞疗法在实体肿瘤治疗中的五大难点

2016-06-18

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

Lancet：Ixmyelocel-T细胞疗法或将是HFrEF患者的福音

2016-04-07

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

【盘点】CAR-T细胞疗法进展一览

2016-03-04

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

癌症治愈？过继T细胞疗法可靶向治疗疾病

2016-02-21

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

震撼：CAR-T细胞疗法CTL019在2期r/r ALL临床试验中获得93%的完全应答率

2015-12-11

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

ASCO 2015：CAR-T细胞疗法正在攻克实体瘤胰腺癌是初露曙光

2015-06-21

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

用于抗癌的嵌合抗原受体T细胞疗法目前已经进入临床试验阶段

2015-01-21

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

Nature：T细胞疗法可延长白血病患者生存期？

2015-01-06

124984edm24暂无昵称 (审核中...)

前往app查看评论内容

#T细胞疗法#

美科学家致力T细胞疗法治疗癌症

2013-07-03

科室
- - 订阅+
  - 更多科室
工具
服务